Regulatory & Compliance in Life Sciences

Regulatory compliance is a critical requirement for pharmaceutical, biotechnology, and medical device companies operating in global markets. Each product must meet strict regulatory standards set by health authorities such as the FDA (United States), EMA (Europe), PMDA (Japan), NMPA (China), and other national regulatory bodies. These agencies require extensive documentation—clinical trial protocols, labeling content, IFUs, SmPCs, and submission dossiers—in multiple languages to ensure product safety and efficacy.

The risks of translation errors in regulatory content are substantial, potentially resulting in delayed approvals, product recalls, or non-compliance penalties. Whether it’s the mistranslation of dosage instructions in a patient leaflet or terminology inconsistencies in a Module 1 submission, the margin for error is zero.

Accurate, high-quality, and fast translation is essential to achieving global regulatory milestones. Life sciences companies must navigate the linguistic and technical complexity of international compliance while managing large volumes of documentation under tight deadlines.

Sesen’s regulatory translation services are designed specifically for this high-stakes environment, combining domain-specific human expertise with AI-powered tools to ensure consistency, efficiency, and full compliance with international standards.

Read More Read Less

The Role of AI in Regulatory & Compliance Translation

AI is transforming how life sciences companies manage regulatory and compliance translation at scale. By automating repetitive processes and supporting linguists with real-time language intelligence, AI accelerates document processing, improves consistency, and reduces time-to-submission.

Advanced Natural Language Processing (NLP) models can classify, extract, and align regulatory content with high precision—supporting faster localization of global regulatory documents without compromising accuracy. AI also ensures terminological consistency across thousands of pages, a critical requirement for meeting EMA, FDA, PMDA, and NMPA expectations.

Common Use Cases:

AI accelerates the preparation and translation of multilingual eCTD modules by reusing aligned content and enforcing structure compliance.

Seamless translation of SPCs, PILs, SmPCs, and IFUs with AI-assisted terminology control and change tracking.

AI improves turnaround time for DSURs, PSURs, and ICSRs, helping teams meet global safety reporting timelines.

NLP models support rapid localization of IRB submissions, ICFs, study protocols, and patient-facing materials—ensuring compliance and participant understanding.

Sesen’s AI-powered translation workflows combine machine learning with expert human oversight to support regulatory teams in managing complexity, reducing costs, and accelerating global market access.

Sesen’s AI Capabilities for Regulatory Translation

Sesen combines deep regulatory expertise with proprietary AI technologies to deliver fast, accurate, and scalable translation solutions tailored to the life sciences sector.

At the core of our AI strategy is SesenGPT, a purpose-built large language model (LLM) trained exclusively on life sciences and regulatory content. Unlike general-purpose AI, SesenGPT is domain-tuned to understand the structure, terminology, and compliance requirements of documents such as SmPCs, IFUs, clinical trial protocols, and regulatory submissions.

Key Capabilities:

Sesen integrates domain-specific AI with professional human linguists to deliver high-accuracy translations that meet global regulatory standards. Our hybrid model ensures speed without sacrificing quality or compliance integrity.

We apply Machine Translation Post-Editing (MTPE) using experienced linguists and regulatory subject matter experts. This ensures content is linguistically accurate, scientifically precise, and submission-ready.

Sesen can fine-tune AI engines using client-specific regulatory datasets, ensuring the translation output aligns with internal style guides, terminology, and prior submissions.

Our AI-powered Translation Memory (TM) and termbase management systems improve version control, enforce consistency, and adapt terminology dynamically across regions and product lines.

This intelligent integration of human and AI capabilities enables Sesen to support complex, high-volume regulatory translation projects while meeting aggressive timelines and strict compliance demands.

Compliance with Industry Standards

Sesen’s regulatory translation services are built on a foundation of certified quality, data integrity, and global compliance. Our AI-enabled workflows meet the strictest industry and regulatory standards required by life sciences organizations.

We are fully certified to ISO 17100 (Translation Services), ISO 9001:2015 (Quality Management), and ISO 13485:2016 (Medical Devices), ensuring that every deliverable meets rigorous quality and traceability requirements.

Our content workflows are aligned with global regulatory expectations, including:

  • EMA QRD templates for centralized EU submissions
  • FDA labeling guidelines and submission protocols
  • PMDA and NMPA language requirements for Asia-Pacific markets

We prioritize data privacy and security across all stages of project execution. Our systems and processes are compliant with:

  • HIPAA (U.S. patient data protection)
  • GDPR (EU data privacy regulation)
  • 21 CFR Part 11 (electronic records and signatures)

Sesen’s AI-powered translation platform is hosted on AWS, leveraging enterprise-grade encryption, secure access controls, and full audit trails to protect sensitive regulatory content throughout the translation lifecycle.

Read More Read Less

AI Use Cases in Regulatory & Compliance Translation

AI plays a critical role in streamlining regulatory and compliance translation workflows across the life sciences industry. By automating repetitive tasks, supporting consistency, and accelerating turnaround times, AI enables regulatory teams to meet global submission requirements with greater efficiency and control—always paired with expert human translators to validate accuracy and compliance.

AI supports the rapid translation and alignment of Summary of Product Characteristics (SmPCs), Patient Information Leaflets (PILs), and Instructions for Use (IFUs) across multiple languages—ensuring consistency with QRD templates and region-specific requirements. All content is reviewed and refined by experienced medical translators to ensure regulatory accuracy.

AI accelerates the translation of electronic Common Technical Document (eCTD) modules, particularly Modules 1 (regional), 2 (summaries), and 5 (clinical study reports), by leveraging NLP for structure recognition, content extraction, and reuse across submissions. Expert linguists specializing in regulatory content perform post-editing and quality assurance to ensure submission readiness.

AI-powered translation enhances the speed and consistency of pharmacovigilance documentation, including Periodic Safety Update Reports (PSURs), Development Safety Update Reports (DSURs), and individual case safety reports (ICSRs), while maintaining compliance with EMA and FDA timelines. Human editors with pharmacovigilance expertise validate terminology and context.

From IRB submissions and investigator brochures to informed consent forms (ICFs) and study protocols, AI facilitates fast, compliant localization of high-volume clinical trial documents. Specialized medical translators ensure cultural appropriateness and regulatory alignment for each target market.

AI aids in identifying and translating updated sections in labeling, safety, and registration documents. Integrated with Translation Memory and terminology databases, AI helps regulatory teams maintain consistency across product families and market updates. Final output is reviewed and approved by professional linguists with regulatory experience.

Sesen’s AI-enhanced translation solutions are designed for accuracy, scale, and compliance—delivering the speed of AI with the quality assurance of professional human translation.

Why Sesen?

Sesen is uniquely positioned at the intersection of AI innovation and regulatory translation excellence. Our solutions are purpose-built for life sciences organizations navigating the complex demands of global compliance and multilingual documentation.

We specialize in regulatory translation across pharmaceuticals, biotechnology, and medical devices, with deep familiarity in EMA, FDA, PMDA, and NMPA requirements. Our linguists and subject matter experts are trained to handle critical documentation such as SmPCs, IFUs, clinical protocols, and safety reports with precision and compliance in mind.

Our proprietary AI technology—combined with professional human translation—enables faster delivery, reduced costs, and higher consistency. Every project leverages AI for scalability, but final output is always reviewed by trained linguists to meet regulatory-grade standards.

We maintain a rigorous multi-step QA process, including in-house linguistic validation and review by regulatory subject matter experts, ensuring that all translations meet technical, scientific, and compliance expectations.

Each client engagement is supported by a dedicated project manager with a background in regulatory affairs or life sciences localization. This ensures smooth communication, proactive risk management, and alignment with submission timelines.

Sesen delivers the speed of AI with the assurance of expert-led workflows, making us the trusted partner for regulatory translation in life sciences.

Let’s Talk About Your Next Regulatory Submission

Whether you’re preparing multilingual eCTD modules, updating IFUs, or translating pharmacovigilance reports, Sesen is ready to support your global regulatory strategy with precision and speed.

Our AI-powered workflows can integrate with leading life sciences platforms such as Veeva Vault, Oracle Argus, and MasterControl, ensuring efficient document handling and version control across your submission lifecycle.

Speak with our team to explore how Sesen can accelerate your next regulatory submission while maintaining full compliance.